Several genes and molecular pathways have been implicated in gender-related differences in immune responses and PD-L1 expression such as estrogen-related, sex hormone-related, immune-related, oncogene, and tumor suppression-related molecular pathways [37,38]. The gene discussed is PLXNA3; the disease is neoplasm.